Inflammatory bowel disease type influences development of elevated liver enzymes

Background and Aim Up to a third of patients with inflammatory bowel disease (IBD) have elevated liver enzymes (ELE). We evaluated the incidence, predictors, and outcomes associated with ELE in a diverse and vulnerable IBD cohort. Methods We retrospectively evaluated 336 IBD patients receiving care...

Full description

Saved in:
Bibliographic Details
Published in:JGH open 2022-12, Vol.6 (12), p.846-853
Main Authors: Cheng, Yao‐Wen, McLean, Richard, Sewell, Justin L, Huang, Chiung‐Yu, Khalili, Mandana
Format: Article
Language:English
Subjects:
Age
Body mass index
Crohn's disease
Diabetes
Drug use
Enzymes
Etiology
Gastroenterology
HIV
Hospitals
Human immunodeficiency virus
Hyperlipidemia
Hypertension
Inflammatory bowel disease
Laboratories
liver disease
Liver diseases
Males
Medical records
Original
Patients
Phosphatase
Risk factors
Steroids
transaminitis
ulcerative colitis
Variables
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Aim Up to a third of patients with inflammatory bowel disease (IBD) have elevated liver enzymes (ELE). We evaluated the incidence, predictors, and outcomes associated with ELE in a diverse and vulnerable IBD cohort. Methods We retrospectively evaluated 336 IBD patients receiving care at the San Francisco safety net gastroenterology clinics between June 1996 and December 2019. Baseline characteristics were captured at first visit, then patients were followed until last clinic activity or death. Testing and etiology, pattern of ELE defined as transient (
ISSN:2397-9070
2397-9070
DOI:10.1002/jgh3.12831